Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Heene

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1997
Measurement of fluorescent-labeled LMM-heparin in biological fluids using protamine-linked microbeadsR Malsch, D Melui, L Piazolo, et al.
Cytometry|January 1, 1996
Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragmentJ Harenberg, R Malsch, L Piazolo, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1985
Unusual mechanism of PR interval variation and nonreentrant supraventricular tachycardia as manifestation of simultaneous anterograde fast and slow conduction through dual atrioventricular nodal pathwaysJ Buss, J Kraatz, B Stegaru, et al.
Thrombosis and Haemostasis|October 6, 1997
Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide AS A Pfitzner, C E Dempfle, M Matsuda, et al.
Zeitschrift Fur Gastroenterologie|December 1, 1986
[Differential diagnosis of jaundice by combined noninvasive diagnostic means using a logistic discriminant analysis]R Elfner, R Gladisch, D Schlauch, et al.
Klinische Wochenschrift|August 15, 1975
[Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)]W H Krause, K Huth, D L Heene, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1976
[Hypercoagulability in patients after heart infarct and malignant tumors]R Reinicke, F R Matthias, H G Lasch, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2000
[Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study]G Huhle, U Hoffmann, I Hoffmann, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Determination of fibrinmonomer (FM) from plasma by affinity chromatography on insolubilized fibrinogen (FG-ag)F R Matthias, R Reinicke, D L Heene, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Platelet adhesion to insolubilized aggregating agentsD L Heene, G Grotemeyer, F R Matthias, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Seminars in Thrombosis and Hemostasis|January 1, 1997
Measurement of fluorescent-labeled LMM-heparin in biological fluids using protamine-linked microbeadsR Malsch, D Melui, L Piazolo, et al.
Cytometry|January 1, 1996
Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragmentJ Harenberg, R Malsch, L Piazolo, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1985
Unusual mechanism of PR interval variation and nonreentrant supraventricular tachycardia as manifestation of simultaneous anterograde fast and slow conduction through dual atrioventricular nodal pathwaysJ Buss, J Kraatz, B Stegaru, et al.
Thrombosis and Haemostasis|October 6, 1997
Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide AS A Pfitzner, C E Dempfle, M Matsuda, et al.
Zeitschrift Fur Gastroenterologie|December 1, 1986
[Differential diagnosis of jaundice by combined noninvasive diagnostic means using a logistic discriminant analysis]R Elfner, R Gladisch, D Schlauch, et al.
Klinische Wochenschrift|August 15, 1975
[Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)]W H Krause, K Huth, D L Heene, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1976
[Hypercoagulability in patients after heart infarct and malignant tumors]R Reinicke, F R Matthias, H G Lasch, et al.
Deutsche Medizinische Wochenschrift (1946)|June 30, 2000
[Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study]G Huhle, U Hoffmann, I Hoffmann, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Determination of fibrinmonomer (FM) from plasma by affinity chromatography on insolubilized fibrinogen (FG-ag)F R Matthias, R Reinicke, D L Heene, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Platelet adhesion to insolubilized aggregating agentsD L Heene, G Grotemeyer, F R Matthias, et al.
Pageof 15